BetterLife Pharma (BETRF) Depreciation & Amortization (CF) (2011 - 2022)
BetterLife Pharma (BETRF) posted quarterly Depreciation & Amortization (CF) of $3470.1 for Q4 2022, down 5.35% year-over-year from $3666.2 in Q4 2021, and down 3.17% quarter-over-quarter from $3583.6 in Q3 2022.
BetterLife Pharma (BETRF) Depreciation & Amortization (CF) (2011 - 2022) Analysis & Trends
BetterLife Pharma's Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $3470.1 for Q4 2022.
- In Q4 2022, Depreciation & Amortization (CF) fell 5.35% year-over-year to $3470.1; the TTM figure through Jul 2023 stood at $3470.1 (down 68.13% YoY), while the FY2016 annual figure was $322.0, down 17.7% from the prior year.
- Depreciation & Amortization (CF) for Q4 2022 stood at $3470.1, down from $3583.6 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $187098.4 in Q4 2019, with the low at $3470.1 in Q4 2022.
- The 3-year median for Depreciation & Amortization (CF) is $3660.9 (2021), against an average of $29838.6.
- Peak annual rise in Depreciation & Amortization (CF) reached 0.6% in 2022, while the deepest fall reached 5.35% in 2022.
- BetterLife Pharma's Depreciation & Amortization (CF) stood at $187098.4 in 2019, then slumped by 98.04% to $3666.2 in 2021, then slipped by 5.35% to $3470.1 in 2022.
- Business Quant data shows BETRF's Depreciation & Amortization (CF) at $3470.1 in Q4 2022, $3583.6 in Q3 2022, and $3639.1 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2022 | 3,470.10 |
| Oct 31, 2022 | 3,470.10 |
| Jul 31, 2022 | 3,583.62 |
| Jul 31, 2022 | 3,583.62 |
| Apr 30, 2022 | 3,639.06 |
| Apr 30, 2022 | 3,639.06 |
| Oct 31, 2021 | 3,666.17 |
| Oct 31, 2021 | 3,666.17 |
| Jul 31, 2021 | 3,751.65 |
| Jul 31, 2021 | 3,751.65 |
| Apr 30, 2021 | 3,660.92 |
| Apr 30, 2021 | 3,660.92 |
| Oct 31, 2019 | 187,098.40 |
| Oct 31, 2019 | 187,098.40 |
| Jan 31, 2016 | 53.00 |
| Jan 31, 2016 | 53.00 |
| Oct 31, 2015 | 86.00 |
| Oct 31, 2015 | 86.00 |
| Jul 31, 2015 | 92.00 |
| Jul 31, 2015 | 92.00 |